NDC 0008-0423
North American Coral Snake Antivenin (Equine)
Coral Snake (micrurus Fulvius) Immune Globulin Antivenin (equine)
North American Coral Snake Antivenin (Equine) is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. The primary component is Coral Snake (micrurus Fulvius) Immune Globulin Antivenin (equine).
| Product ID | 0008-0423_52d0cf5a-e3d9-4705-8b50-9ca7c8c78578 |
| NDC | 0008-0423 |
| Product Type | Human Prescription Drug |
| Proprietary Name | North American Coral Snake Antivenin (Equine) |
| Generic Name | Coral Snake (micrurus Fulvius) Immune Globulin Antivenin (equine) |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2016-10-12 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101099 |
| Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| Substance Name | CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE) |
| Active Ingredient Strength | 250 [arb'U]/10mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |